AJP - Endocrinology and Metabolism, Vol 254, Issue 1 E1-15, Copyright © 1988 by American Physiological Society

ARTICLES

Physiology and pathophysiology of atrial peptides

K. L. Goetz
Division of Experimental Medicine, St. Luke's Hospital and Foundation,Kansas City, MO 64111.

The atria secrete atrial peptides (atriopeptins) that are capable of producing dramatic alterations in a number of body processes. Secretion of atriopeptin appears to be regulated primarily by the prevailing pressure within the atria. In pharmacological doses, atriopeptin rapidly elicits a natriuresis when administered to experimental animals or humans. In contrast, infusion rates that increase plasma atriopeptin only by about three- to fivefold tend to produce a slowly developing and modest diuresis. Evidence examined in this review suggests that the atrial peptides are not potent natriuretic substances under normal physiological conditions, although it is likely that they exert a modulating influence on sodium excretion. The atrial peptides are vasoactive and induce a number of cardiovascular changes including decreases in arterial blood pressure, cardiac filling pressure, and cardiac output and a translocation of fluid from plasma to the interstitial fluid space. They also interact with other hormones, particularly the renin-angiotensin-aldosterone system. Finally, atriopeptin is distributed throughout many regions of the brain where it may serve as a neuromodulator or neurotransmitter. Atriopeptin circulating in the bloodstream also may influence cerebral mechanisms by acting on receptors in the circumventricular organs. A more complete understanding of the diverse effects of this cardiac endocrine system is expected to provide further insight into a spectrum of physiological and pathophysiological processes.

This article has been cited by other articles:

				S. A. Kavouras, L. E. Armstrong, C. M. Maresh, D. J. Casa, J. A. Herrera-Soto, T. P. Scheett, J. Stoppani, G. W. Mack, and W. J. Kraemer Rehydration with glycerol: endocrine, cardiovascular, and thermoregulatory responses during exercise in the heat J Appl Physiol, February 1, 2006; 100(2): 442 - 450. [Abstract] [Full Text] [PDF]

				S. L. Tam, E. Sims, and S. Kaufman Effect of NOS inhibition on central response to atrial distension during pregnancy Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R827 - R831. [Abstract] [Full Text] [PDF]

				E. N. Brown, P. M. Meehan, and A. P. Dempster A stochastic differential equation model of diurnal cortisol patterns Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E450 - E461. [Abstract] [Full Text] [PDF]

				P. Lai, S. J. Nazian, W. R. Gower Jr., C. S. Landon, and J. R. Dietz Increased Bioactivity of Rat Atrial Extracts: Relation to Aging and Blood Pressure Regulation J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2000; 55(8): 390B - 395. [Abstract] [Full Text]

				H. Berkenstadt, T. Rosenthal, E. Peleg, E. Segal, A. Hackshaw, G. Ben-Ari, and A. Perel Elevated Plasma Atrial Natriuretic Peptide Levels After Occlusion of the Thoracic Aorta Chest, January 1, 1999; 115(1): 130 - 134. [Abstract] [Full Text] [PDF]

				J. D. STOCKAND and S. C. SANSOM Glomerular Mesangial Cells: Electrophysiology and Regulation of Contraction Physiol Rev, July 1, 1998; 78(3): 723 - 744. [Abstract] [Full Text] [PDF]

				K. Fujishige, N. Yanaka, H. Akatsuka, and K. Omori Localization of clearance receptor in rat lung and trachea: association with chondrogenic differentiation Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L425 - L431. [Abstract] [Full Text] [PDF]

				H. Poulsen, P. Olofsson, and M. Stjernquist Effects of Head-Down Tilt on Atrial Natriuretic Peptide and the Renin System in Pregnancy Hypertension, June 1, 1995; 25(6): 1161 - 1166. [Abstract] [Full Text]

				Z.-H. Miao, D.-L. Song, J. G. Douglas, and C.-H. Chang Mutational Inactivation of the Catalytic Domain of Guanylate Cyclase-A Receptor Hypertension, April 1, 1995; 25(4): 694 - 698. [Abstract] [Full Text]